MyJournals Home  

RSS FeedsDeveloping Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets (Drug Safety)

 
 

14 january 2020 19:03:02

 
Developing Predictive Models to Determine Patients in End-of-Life Care in Administrative Datasets (Drug Safety)
 


Abstract Introduction In observational studies with mortality endpoints, one needs to consider how to account for subjects whose interventions appear to be part of `end-of-life` care. Objective The objective of this study was to develop a diagnostic predictive model to identify those in end-of-life care at the time of a drug exposure. Methods We used data from four administrative claims datasets from 2000 to 2017. The index date was the date of the first prescription for the last new drug subjects received during their observation period. The outcome of end-of-life care was determined by the presence of one or more codes indicating terminal or hospice care. Models were developed using regularized logistic regression. Internal validation was through examination of the area under the receiver operating characteristic curve (AUC) and through model calibration in a 25% subset of the data held back from model training. External validation was through examination of the AUC after applying the model learned on one dataset to the three other datasets. Results The models showed excellent performance characteristics. Internal validation resulted in AUCs ranging from 0.918 (95% confidence interval [CI] 0.905-0.930) to 0.983 (95% CI 0.978-0.987) for the four different datasets. Calibration results were also very good, with slopes near unity. External validation also produced very good to excellent performance metrics, with AUCs ranging from 0.840 (95% CI 0.834-0.846) to 0.956 (95% CI 0.952-0.960). Conclusion These results show that developing diagnostic predictive models for determining subjects in end-of-life care at the time of a drug treatment is possible and may improve the validity of the risk profile for those treatments.


 
180 viewsCategory: Pharmacology
 
A New President`s Vision for International Pharmacovigilance (Drug Safety)
Publisher Correction: Breast cancer drug approvals by the US FDA from 1949 to 2018 (Nature Reviews Drug Discovery)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten